Related Experiment Video
Updated: Jun 12, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease
A G Thomas1, J M Holly, F Taylor
1Department of Gastroenterology, Booth Hall Children's Hospital, Blackley, Manchester.
Abstract:
Twenty nine children with Crohn's disease were studied before and after treatment with steroids or an elemental diet to assess the effect of disease activity and treatment on serum insulin like growth factor I (IGF-I), insulin like growth factor binding protein (IGFBP-1), and insulin concentrations. The median serum IGF-I concentration was lower in patients with active disease than in matched controls, and lower in stunted than well grown patients, but insulin and IGFBP-1 concentrations were not significantly different between any group. After four weeks of either treatment there was an increase in the median serum IGF-I concentration; this was greater in the steroid group than the elemental diet group. The median serum insulin concentration increased and median serum IGFBP-1 concentration decreased in the steroid treated group but not in the elemental diet group. These changes were accompanied by a greater and more sustained increase in energy intake in the steroid group. Despite this the median height velocity SD score was greater in the elemental diet group than in the steroid group.
More Related Videos
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
08:34Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay
Published on: July 15, 2025
Related Concept Videos
Insulin Secretory Vesicles
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Insulin: The Receptor and Signaling Pathways
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease